{"disease":{"id":"unverricht-lundborg-disease","name":"unverricht lundborg disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06593951","title":"Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT03351569","title":"Intravenous Immunoglobulin for Unverricht-Lundborg Disease.","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1,"lead_sponsor_name":"Azienda Socio Sanitaria Territoriale di Mantova","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}